Cognex Corporation $CGNX Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its position in Cognex Corporation (NASDAQ:CGNXFree Report) by 91.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 80,908 shares of the scientific and technical instruments company’s stock after buying an additional 38,643 shares during the period. Assenagon Asset Management S.A.’s holdings in Cognex were worth $3,964,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Geneos Wealth Management Inc. raised its position in shares of Cognex by 402.2% during the 1st quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after buying an additional 736 shares during the period. CIBC Private Wealth Group LLC grew its position in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 327 shares during the period. Miller Global Investments LLC purchased a new position in Cognex in the fourth quarter worth approximately $39,000. Caitong International Asset Management Co. Ltd acquired a new stake in Cognex during the fourth quarter worth $39,000. Finally, Larson Financial Group LLC increased its stake in Cognex by 202.7% during the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company’s stock worth $40,000 after acquiring an additional 740 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Cognex Stock Performance

Shares of CGNX opened at $68.36 on Tuesday. The company’s 50-day simple moving average is $62.59 and its 200-day simple moving average is $51.58. Cognex Corporation has a 1 year low of $31.42 and a 1 year high of $71.90. The stock has a market capitalization of $11.38 billion, a PE ratio of 81.38 and a beta of 1.52.

Cognex (NASDAQ:CGNXGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.09. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm had revenue of $268.44 million during the quarter, compared to analysts’ expectations of $245.98 million. During the same quarter in the previous year, the business posted $0.14 earnings per share. The business’s quarterly revenue was up 24.3% compared to the same quarter last year. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, sell-side analysts predict that Cognex Corporation will post 1.49 earnings per share for the current year.

Cognex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were given a $0.085 dividend. This represents a $0.34 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 21st. Cognex’s dividend payout ratio (DPR) is currently 40.48%.

Analysts Set New Price Targets

CGNX has been the topic of several recent analyst reports. Robert W. Baird set a $72.00 price target on Cognex in a research note on Friday, May 8th. Zacks Research raised Cognex from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 16th. Needham & Company LLC boosted their price objective on shares of Cognex from $67.00 to $75.00 and gave the company a “buy” rating in a report on Friday, May 8th. JPMorgan Chase & Co. raised shares of Cognex from a “neutral” rating to an “overweight” rating and upped their target price for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th. Finally, Seaport Research Partners set a $75.00 target price on shares of Cognex in a research note on Tuesday, May 26th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $70.43.

Read Our Latest Stock Analysis on CGNX

Insiders Place Their Bets

In other Cognex news, VP Darren Marc Long sold 20,252 shares of the business’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares in the company, valued at $264,696.60. The trade was a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Mark Fennell sold 64,873 shares of the company’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.05, for a total value of $4,349,734.65. Following the sale, the insider directly owned 11,263 shares in the company, valued at $755,184.15. This represents a 85.21% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 224,847 shares of company stock worth $14,975,098 over the last 90 days. Corporate insiders own 1.70% of the company’s stock.

Cognex Profile

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

See Also

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNXFree Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.